Humibid L.A. 300 mg / 600 mg Extended Release Oral Tablet, Reformulated Apr 2009
RxNorm 848060
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 848060 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Humibid L.A. 300 mg / 600 mg Extended Release Oral Tablet, Reformulated Apr 2009.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Guaiacolsulfonate 300 mg / guaifenesin 600 mg Extended Release Oral Tablet [Humibid L.A. Reformulated Apr 2009]
(Atom ID: 12369472)
TMSY
Tall Man Lettering Synonym (TMSY):
Guaiacolsulfonate 300 mg / guaiFENesin 600 mg Extended Release Oral Tablet [Humibid L.A. Reformulated Apr 2009]
(Atom ID: 6377303)
PSN
Prescribable Name (PSN):
Humibid L.A. 300 mg / 600 mg Extended Release Oral Tablet, Reformulated Apr 2009
(Atom ID: 6366690)
SY
Synonym (SY):
Humibid L.A. Reformulated Apr 2009 (Guaiacolsulfonate 300 mg / Guaifenesin 600 mg) Extended Release Oral Tablet
(Atom ID: 6358191)
TMSY
Tall Man Lettering Synonym (TMSY):
Humibid L.A. Reformulated Apr 2009 (Guaiacolsulfonate 300 mg / guaiFENesin 600 mg) Extended Release Oral Tablet
(Atom ID: 6376247)
SY